ArticleAmerican journal of physiology. Heart and circulatory physiology2026
Emerging biomarkers for improved risk prediction of atrial fibrillation: potential role of bone morphogenic protein 10.
Florian Bruns, Anke C Fender, Dobromir Dobrev
Abstract readComment
In one paragraphArticle in American journal of physiology. Heart and circulatory physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
3 authors.
Florian BrunsInstitute of Pharmacology, West German Heart and Vascular Center, University Duisburg-Essen, Essen, Germany.ORCID 0000-0001-9800-850X Anke C FenderInstitute of Pharmacology, West German Heart and Vascular Center, University Duisburg-Essen, Essen, Germany.ORCID 0000-0003-3965-6165 Dobromir DobrevInstitute of Pharmacology, West German Heart and Vascular Center, University Duisburg-Essen, Essen, Germany.ORCID 0000-0002-4612-117X Funding
The Role of Inflammasome in the Pathogenesis of Atrial FibrillationR01HL136389 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI Na Li · 2017 to 2026
$5.6MResolution of inflammation and atrial fibrillationR01HL165704 · NHLBI · UNIVERSITY OF MINNESOTA · PI SAMUEL C DUDLEY · 2023 to 2026
$2.9MCardiac fibroblast inflammasome and atrial myopathyR01HL163277 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI LI, NA · 2022 to 2025
$2.8MRole of Nucleoside-Diphosphate Kinase Signaling in Atrial FibrillationR01HL160992 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI Xander H.T. Wehrens · 2023 to 2026
$2.1MFKBP5 AND CARDIAC ARRHYTHMOGENESISR01HL164838 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI Na Li · 2024 to 2026
$1.7MCalcium Driven Fibroblast Dysregulation in Human Atrial Profibrotic RemodelingR01HL176651 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Eleonora Grandi · 2025 to 2026
$1.1MDeutsche Forschungsgemeinschaft (DFG) FE 1365/4-1Deutsche Forschungsgemeinschaft (DFG) Research Training Group 2989EC | Horizon 2020 Framework Programme (H2020) 965286HHS | National Institutes of Health (NIH) R01HL136389HHS | National Institutes of Health (NIH) R01HL160992HHS | National Institutes of Health (NIH) R01HL163277HHS | National Institutes of Health (NIH) R01HL164838HHS | National Institutes of Health (NIH) R01HL165704HHS | National Institutes of Health (NIH) R01HL176651NHLBI NIH HHS R01 HL136389NHLBI NIH HHS R01 HL160992NHLBI NIH HHS R01 HL163277NHLBI NIH HHS R01 HL164838NHLBI NIH HHS R01 HL165704NHLBI NIH HHS R01 HL176651
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
atrial cardiomyopathyatrial fibrillationbiomarkersBMP10
Identifiers
PMID41696802
PMCPMC13010452
What Socratic holds
Textmetadata
LicenceTDM
Read underepoch 390